Rachel Ostroff

6.1k total citations
49 papers, 1.6k citations indexed

About

Rachel Ostroff is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Rachel Ostroff has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Biomedical Engineering. Recurrent topics in Rachel Ostroff's work include Advanced biosensing and bioanalysis techniques (10 papers), Biosensors and Analytical Detection (9 papers) and Advanced Proteomics Techniques and Applications (8 papers). Rachel Ostroff is often cited by papers focused on Advanced biosensing and bioanalysis techniques (10 papers), Biosensors and Analytical Detection (9 papers) and Advanced Proteomics Techniques and Applications (8 papers). Rachel Ostroff collaborates with scholars based in United States, United Kingdom and Germany. Rachel Ostroff's co-authors include Michael L. Vasil, Adriana I. Vasil, Stephen A. Williams, Edward N. Brody, Bengt Wretlind, Larry Gold, Dom Zichi, Jeffrey J. Walker, Michael R. Mehan and Harvey I. Pass and has published in prestigious journals such as Circulation, Nature Medicine and Nature Communications.

In The Last Decade

Rachel Ostroff

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Ostroff United States 25 910 218 203 189 189 49 1.6k
James D. Chang United States 19 729 0.8× 142 0.7× 235 1.2× 243 1.3× 55 0.3× 55 1.7k
Gary Woodnutt United States 21 1.1k 1.2× 106 0.5× 217 1.1× 237 1.3× 55 0.3× 45 1.9k
Erin H. Seeley United States 27 1.7k 1.9× 227 1.0× 169 0.8× 228 1.2× 107 0.6× 55 3.1k
David H. Goetz United States 15 934 1.0× 281 1.3× 177 0.9× 340 1.8× 42 0.2× 17 2.7k
Kazuyuki Sogawa Japan 23 556 0.6× 118 0.5× 57 0.3× 299 1.6× 68 0.4× 77 1.6k
Takanori Sakaguchi Japan 28 748 0.8× 498 2.3× 211 1.0× 314 1.7× 95 0.5× 125 2.6k
Jochen Metzger Germany 24 871 1.0× 319 1.5× 170 0.8× 322 1.7× 217 1.1× 66 2.8k
Edward Tarelli United Kingdom 21 772 0.8× 113 0.5× 143 0.7× 298 1.6× 73 0.4× 66 1.8k
Jie Lu China 35 1.5k 1.6× 165 0.8× 184 0.9× 1.0k 5.5× 61 0.3× 169 3.7k
Hayato Miyachi Japan 25 907 1.0× 170 0.8× 81 0.4× 218 1.2× 84 0.4× 163 2.1k

Countries citing papers authored by Rachel Ostroff

Since Specialization
Citations

This map shows the geographic impact of Rachel Ostroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Ostroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Ostroff more than expected).

Fields of papers citing papers by Rachel Ostroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Ostroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Ostroff. The network helps show where Rachel Ostroff may publish in the future.

Co-authorship network of co-authors of Rachel Ostroff

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Ostroff. A scholar is included among the top collaborators of Rachel Ostroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Ostroff. Rachel Ostroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asselbergs, Folkert W., Magdaléna Harakaľová, K. Martijn Akkerhuis, et al.. (2023). HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms. EBioMedicine. 93. 104655–104655. 16 indexed citations
2.
Rueten‐Budde, Anja J., K. Martijn Akkerhuis, Victor A. Umans, et al.. (2023). Machine learning–based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure. European Heart Journal - Digital Health. 4(6). 444–454. 6 indexed citations
3.
Sanyal, Arun J., Stephen A. Williams, Joel E. Lavine, et al.. (2022). Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. Journal of Hepatology. 78(4). 693–703. 48 indexed citations
4.
Carrasco-Zanini, Julia, Maik Pietzner, Joni V. Lindbohm, et al.. (2022). Proteomic signatures for identification of impaired glucose tolerance. Nature Medicine. 28(11). 2293–2300. 26 indexed citations
5.
Pietzner, Maik, Eleanor Wheeler, Julia Carrasco-Zanini, et al.. (2021). Author Correction: Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nature Communications. 12(1). 845–845.
6.
Ferrannini, Giulia, Maria Laura Manca, Marco Magnoni, et al.. (2020). Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care. 43(4). 843–851. 44 indexed citations
7.
Pietzner, Maik, Eleanor Wheeler, Julia Carrasco-Zanini, et al.. (2020). Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nature Communications. 11(1). 6397–6397. 69 indexed citations
8.
Groote, Mary Ann De, David G. Sterling, Thomas Hraha, et al.. (2017). Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis. Journal of Clinical Microbiology. 55(10). 3057–3071. 65 indexed citations
9.
Williams, Stephen A., Robert Kirk DeLisle, Craig Hyde, et al.. (2017). Improving Assessment of Drug Safety Through Proteomics. Circulation. 137(10). 999–1010. 25 indexed citations
10.
DeLisle, Robert Kirk, Peter Ganz, Evaldas Katilius, et al.. (2016). Abstract 17082: Translation From Highly Multiplexed Biomarker Discovery to a Targeted Protein Panel to Stratify Cardiovascular Risk in Patients With Coronary Heart Disease. Circulation. 134. 1 indexed citations
11.
Jung, Young Ju, Evaldas Katilius, Rachel Ostroff, et al.. (2016). Development of a Protein Biomarker Panel to Detect Non–Small-Cell Lung Cancer in Korea. Clinical Lung Cancer. 18(2). e99–e107. 35 indexed citations
12.
Vasil, Michael L., et al.. (2015). Phospholipase C: Molecular Biology and Contribution to the Pathogenesis of Pseudomonas aeruginosa1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 44. 34–47. 5 indexed citations
13.
Mehan, Michael R., Deborah Ayers, Derek Thirstrup, et al.. (2012). Protein Signature of Lung Cancer Tissues. PLoS ONE. 7(4). e35157–e35157. 70 indexed citations
14.
Brand, Randall E., Malte Buchholz, Mike Mehan, et al.. (2012). Detection of resectable pancreatic cancer with SOMAmer proteomic technology.. Journal of Clinical Oncology. 30(4_suppl). 162–162. 1 indexed citations
15.
Mehan, Michael R., Rachel Ostroff, Sheri K. Wilcox, et al.. (2012). Highly Multiplexed Proteomic Platform for Biomarker Discovery, Diagnostics, and Therapeutics. Advances in experimental medicine and biology. 735. 283–300. 55 indexed citations
16.
Ostroff, Rachel, William L. Bigbee, Wilbur A. Franklin, et al.. (2010). Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer. PLoS ONE. 5(12). e15003–e15003. 163 indexed citations
17.
Ostroff, Rachel, Trudi Foreman, Tracy R. Keeney, et al.. (2009). The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. Journal of Proteomics. 73(3). 649–666. 58 indexed citations
18.
Ostroff, Rachel, et al.. (1998). RAPID DETECTION OF GROUP A STREPTOCOCCAL ANTIGEN WITH A NEW OPTICAL IMMUNOASSAY. The Pediatric Infectious Disease Journal. 17(4). 349–351. 14 indexed citations
19.
Ostroff, Rachel, et al.. (1995). Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of Group B Streptococcus by culture and the STREP B OIA test. Diagnostic Microbiology and Infectious Disease. 22(3). 253–259. 26 indexed citations
20.
Ostroff, Rachel & Robert A. Sclafani. (1995). Cell cycle regulation of induced mutagenesis in yeast. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 329(2). 143–152. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James D. Chang Breakdown of academic impact, for papers by Gary Woodnutt Breakdown of academic impact, for papers by Erin H. Seeley Breakdown of academic impact, for papers by David H. Goetz Breakdown of academic impact, for papers by Kazuyuki Sogawa Breakdown of academic impact, for papers by Takanori Sakaguchi Breakdown of academic impact, for papers by Jochen Metzger Breakdown of academic impact, for papers by Edward Tarelli Breakdown of academic impact, for papers by Jie Lu Breakdown of academic impact, for papers by Hayato Miyachi
Rankless by CCL
2026